Teva Pharm Q1 profit misses estimates, revenue risea
By Steven Scheer JERUSALEM (Reuters) - Teva Pharmaceutical Industries reported a smaller than expected rise in first-quarter profit citing higher impairments of tangible assets, while sales of copycat medicines and its branded drugs to treat migrai...
18h ago
Pfizer agrees to settle over 10,000 Zantac lawsuits, Bloomberg News reports
(Reuters) -Pfizer has agreed to settle more than 10,000 lawsuits about cancer risks related to the now discontinued heartburn drug Zantac, Bloomberg News reported on Wednesday, citing people familiar with the deal. The agreements cover cases in U.S. st...
18h ago
Vitamin Shoppe's telehealth service to provide access to weight-loss drugs
(Reuters) - Health and wellness products retailer Vitamin Shoppe said on Wednesday that subscribers to its telehealth service would have access to weight-loss medications such as Ozempic, Mounjaro and Rybelsus. Monthly medication subscription to th...
20h ago
Thai PM says cannabis to be re-listed as narcotic by end of 2024
BANGKOK (Reuters) - Thai Prime Minister Srettha Thavisin said on Wednesday that cannabis would be re-listed as a narcotic by end of 2024, in a stunning U-turn for the country two years after it became the first in the region to decriminalise its re...
21h ago
Teva and Medincell's schizophrenia drug meets main goal of late-stage study
(Reuters) -Israel-based Teva Pharmaceuticals and French partner Medincell said on Wednesday their injectable form of a schizophrenia drug had met its main goal in a late-stage study. TEV-'749, an under-the-skin version of a generic antipsychotic drug c...
21h ago
Europe in whooping cough epidemic as cases soar, says health agency
LONDON (Reuters) - Countries across Europe reported a huge rise in whooping cough cases in 2023 and the first three months of 2024, with ten times as many identified as in each of the previous two years. In total, there were nearly 60,000 cases rep...
23h ago
McKesson misses quarterly estimates as US pharmaceuticals segment weighs
(Reuters) - McKesson Corp reported weaker-than-expected quarterly revenue and profit on Tuesday due to slump in demand for the company's branded and specialty drugs that dragged sales in its U.S. pharmaceutical segment. The drug distributor's pharm...
May 07, 2024
Bio-Rad Laboratories reiterates 2024 revenue growth outlook; shares slip
(Reuters) - Diagnostics firm Bio Rad Laboratories reiterated its 2024 sales growth forecast on Tuesday, weighed by persistently weak spending by biotech companies and sluggish demand in China. The supplier of laboratory apparatus and instruments fo...
May 07, 2024
Pfizer reports patient death in Duchenne gene therapy study
(Reuters) - A young boy died due to a cardiac arrest in a mid-stage trial that tested Pfizer's experimental gene therapy for a muscle-wasting disorder called Duchenne muscular dystrophy (DMD), the drugmaker told Reuters on Tuesday. "A fatal serious...
May 07, 2024
Idaho will seek to revive 'abortion trafficking' law in US appeals court
By Brendan Pierson (Reuters) - Idaho will urge a federal appeals court on Tuesday to revive a 2023 law making it a crime to help a minor cross state lines for an abortion without her parent's consent, which a judge blocked in November. A three-judg...
May 07, 2024